For the quarter ending 2025-09-30, DHC had $61,042K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -164,040 | -100,625 |
| Depreciation and amortization | 65,324 | 134,591 |
| Net amortization of debt discounts, premiums and issuance costs | 20,121 | 45,973 |
| Payment of accreted interest on senior secured notes | 52,292 | 34,700 |
| Straight line rental income | 450 | 309 |
| Amortization of acquired real estate leases and other intangible assets, net | 29 | 54 |
| Loss on modification or early extinguishment of debt | -11,191 | -29,197 |
| Impairment of assets | 93,243 | 69,465 |
| (gain) loss on sale of properties | 1,260 | 102,711 |
| Gain on insurance recoveries | 0 | 7,522 |
| Other non-cash adjustments, net | -221 | 231 |
| Unconsolidated joint venture distributions | 250 | 0 |
| Equity in net (earnings) losses of investees | 5,083 | 4,569 |
| Deferred leasing costs, net | 583 | 2,690 |
| Other assets | 22,600 | -11,427 |
| Accrued interest | -10,997 | 313 |
| Other liabilities | 17,641 | 12,114 |
| Net cash provided by operating activities | -49,285 | 49,777 |
| Real estate improvements | 40,558 | 73,831 |
| Proceeds from sale of properties, net | 15,274 | 334,108 |
| Investment in alerislife inc | 0 | 0 |
| Equity method investment distributions | 31,400 | 17,000 |
| Contributions to unconsolidated joint ventures | 0 | 8,500 |
| Proceeds from insurance recoveries | 0 | 1,308 |
| Purchase of interest rate cap | 0 | 47 |
| Net cash provided by (used in) investing activities | 6,116 | 270,038 |
| Proceeds from issuance of senior secured notes, net | 369,375 | - |
| Proceeds from mortgage notes payable | 0 | 343,157 |
| Redemption of senior secured notes | 244,813 | 238,555 |
| Redemption of senior unsecured notes | 0 | 380,000 |
| Repayment of other debt | 1,069 | 1,659 |
| Early extinguishment of debt settled in cash | 9,901 | 25,903 |
| Payment of debt issuance costs | 6,013 | 13,193 |
| Repurchase of common shares | 954 | 109 |
| Distributions to shareholders | 2,414 | 4,826 |
| Net cash (used in) provided by financing activities | 104,211 | -321,088 |
| Increase in cash and cash equivalents and restricted cash | 61,042 | -1,273 |
| Cash and cash equivalents at beginning of period | 149,854 | - |
| Cash and cash equivalents at end of period | 209,623 | - |
DIVERSIFIED HEALTHCARE TRUST (DHC)
DIVERSIFIED HEALTHCARE TRUST (DHC)